最新报道:According to the news from Bijie.com, on September 22, the Hong Kong-listed company Huajian Medical issued an announcement stating that its company and its subsidiaries ETHKInc and ETHKHOLDINGS LIMITED signed a US$1.5 billion strategic cooperation agreement with Transcenta Pharmaceuticals Co., Ltd. and its subsidiary Transcenta Oncology Inc. on matters related to the potential tokenization of innovative drug pipeline assets (RWA).